酵素免疫分析法市場按產品類型、技術、應用、檢體類型、自動化程度、最終用戶和地區分類

預計到 2025 年，酵素免疫分析法市場規模將達到 191.4 億美元，到 2032 年將達到 248.5 億美元，2025 年至 2032 年的複合年成長率為 3.8%。

全球酵素免疫分析法市場是更廣泛的診斷檢測行業的重要組成部分，它結合了免疫反應的特異性和酶的催化特性，能夠檢測和定量多種生物物質。酵素免疫分析法酵素結合免疫吸附檢測法（ELISA）將抗體-抗原交互作用與酵素反應相結合，產生可測量的訊號，從而能夠精確檢測臨床檢體中的蛋白質、荷爾蒙、病原體和其他生物標記。

這項技術已成為臨床診斷、藥物研發、食品安全檢測和環境監測等多個領域不可或缺的一部分。市面上的產品種類繁多，旨在滿足特定的分析需求，例如夾心ELISA、競爭性ELISA、間接ELISA和直接ELISA。隨著人們越來越關注疾病早期檢測、個人化醫療和就地檢驗，酵素免疫分析法也在不斷發展，以提高靈敏度、特異性和快速出結果的能力。

市場動態

全球酵素免疫分析法市場的主要驅動力是糖尿病、心血管疾病、感染疾病和癌症等慢性疾病的日益流行，這些疾病使得全球醫療保健系統需要頻繁的診斷監測和篩檢計畫。全球人口老化，加上人們健康意識的提高以及政府為促進預防性醫療保健所採取的舉措，都顯著推動了對可靠診斷解決方案的需求。檢測技術的發展，特別是多重檢測平台、自動化系統和照護現場設備的引入，提高了檢測效率並擴展了市場應用。然而，市場也存在諸多限制因素，例如診斷設備核准的嚴格監管要求。這些要求往往導致漫長而高成本的檢驗過程，從而延遲產品上市並增加研發成本。

先進酵素免疫分析法(EIA) 設備的高成本以及操作複雜系統需要熟練技術人員，構成了額外的障礙，尤其是在醫療預算有限的新興市場。來自化學冷光免疫檢測(CLIA)、分子診斷和快速抗原檢測等替代診斷技術的競爭，帶來了價格壓力和市場佔有率挑戰。然而，新興市場也蘊藏著巨大的應用拓展機遇，這些市場醫療基礎設施的改善和可支配收入的成長正在推動對診斷服務的需求。人們對個人化醫療、伴隨診斷和生物標記發現的日益關注，為市場成長開闢了新的途徑，而人工智慧和數位健康平台的整合則有望提升檢測效能和資料管理能力。

本次調查的主要特點

• 本報告對全球酵素免疫分析法市場進行了詳細分析，以 2024 年為基準年，給出了預測期（2025-2032 年）的市場規模（十億美元）和復合年成長率（%）。
• 它還重點介紹了各個細分市場的潛在商機，並說明了該市場具有吸引力的投資提案矩陣。
• 該研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
• 本報告根據以下參數介紹了全球酵素免疫分析法市場主要企業的概況：公司概況、產品系列、主要亮點、財務表現和策略。
• 本報告的研究結果將有助於負責人和經營團隊就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
• 這份全球酵素免疫分析法市場報告的目標受眾是該行業的各類相關人員，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
• 相關人員可以透過全球酵素免疫分析法市場分析中使用的各種策略矩陣輕鬆做出決策。

目錄

第1章 研究目標與前提條件

• 調查目的
• 先決條件
• 簡稱

第2章 市場範圍

• 報告概述
  • 市場定義和範圍
• 執行摘要

第3章 市場動態、監理及趨勢分析

• 市場動態
• 促進要素
• 抑制因素
• 機會
• 影響分析
• 重大進展
• 法規環境
• 產品上市及核准
• PEST分析
• 波特分析
• 併購趨勢
• 產業趨勢

4. 2020-2032年全球酵素免疫分析法市場（依產品類型分類）

• 試劑和試劑盒
• 分析儀/設備
• 軟體和自動化系統
• 耗材和配件

5. 2020-2032年全球酵素免疫分析法市場（依技術分類）

• 酵素免疫分析法（ELISA）
• 酵素連結螢光測定法（ELFA）
• 化學冷光酵素免疫分析法（CL-EIA）
• 快速酵素免疫分析法
• 多重酵素免疫分析法

6. 2020-2032年全球酵素免疫分析法市場（依應用領域分類）

• 感染疾病診斷
• 腫瘤學
• 心臟病學
• 自體免疫疾病
• 內分泌學
• 藥物監測與毒理學
• 過敏測試
• 其他

7. 2020-2032年全球酵素免疫分析法市場（依檢體類型分類）

• 血液/血清
• 尿
• 唾液
• 組織樣本
• 其他（腦脊髓液、血漿）

8. 2020-2032年全球酵素免疫分析法市場（依自動化程度分類）

• 手動的
• 半自動
• 全自動

9. 2020-2032年全球酵素免疫分析法市場（依最終用戶分類）

• 醫院和診所
• 診斷檢查室
• 研究和學術機構
• 製藥和生物技術公司
• 合約研究組織（CRO）

10. 2020-2032年全球酵素免疫分析法市場（按地區分類）

• 北美洲
  • 美國
  • 加拿大
• 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲國家
• 歐洲
  • 德國
  • 英國
  • 西班牙
  • 法國
  • 義大利
  • 俄羅斯
  • 其他歐洲
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • ASEAN
  • 亞太其他地區
• 中東
  • 海灣合作理事會國家
  • 以色列
  • 其他中東國家
• 非洲
  • 南非
  • 北非
  • 中非

第11章 競爭格局

• Abbott
• Roche Diagnostics
• Siemens Healthineers
• bioMerieux
• Beckman Coulter（Danaher）
• Thermo Fisher Scientific
• Bio-Rad Laboratories
• Revvity（PerkinElmer）
• DiaSorin
• QuidelOrtho
• EUROIMMUN（a Revvity company）
• Randox Laboratories
• Bio-Techne（R&D;Systems）
• Merck KGaA（MilliporeSigma）
• Tecan

第12章 分析師建議

• 機會
• 分析師觀點
• Coherent Opportunity Map

第13章 參考文獻與調查方法

• 參考
• 調查方法
• 關於出版商

Enzyme Immunoassay Market is estimated to be valued at USD 19.14 Bn in 2025 and is expected to reach USD 24.85 Bn by 2032, growing at a compound annual growth rate (CAGR) of 3.8% from 2025 to 2032.

The global enzyme immunoassay market represents a critical segment within the broader diagnostic testing industry, leveraging the specificity of immunological reactions combined with the catalytic properties of enzymes to detect and quantify various biological substances. Enzyme immunoassays, also known as enzyme-linked immunosorbent assays (ELISA), utilize antibody-antigen interactions coupled with enzymatic reactions to produce measurable signals, enabling precise detection of proteins, hormones, pathogens, and other biomarkers in clinical samples.

This technology has become indispensable across multiple sectors including clinical diagnostics, pharmaceutical research, food safety testing, and environmental monitoring. The market encompasses various formats such as sandwich ELISA, competitive ELISA, indirect ELISA, and direct ELISA, each designed to address specific analytical requirements. With increasing emphasis on early disease detection, personalized medicine, and point-of-care testing, enzyme immunoassays have evolved to offer enhanced sensitivity, specificity, and rapid turnaround times.

Market Dynamics

The global enzyme immunoassay market is primarily driven by the escalating prevalence of chronic diseases including diabetes, cardiovascular disorders, infectious diseases, and cancer, which necessitate frequent diagnostic monitoring and screening programs across healthcare systems globally. The aging global population, coupled with increasing healthcare awareness and government initiatives promoting preventive healthcare, has significantly boosted demand for reliable diagnostic solutions. Technological advancements in assay development, including the introduction of multiplexed platforms, automated systems, and point-of-care devices, have enhanced testing efficiency and expanded market applications. However, the market faces substantial restraints including stringent regulatory requirements for diagnostic device approvals, which often result in lengthy and costly validation processes that can delay product launches and increase development expenses.

The high cost associated with advanced EIA instruments and the requirement for skilled technical personnel to operate sophisticated systems pose additional barriers, particularly in emerging markets with limited healthcare budgets. Competition from alternative diagnostic technologies such as chemiluminescent immunoassays (CLIA), molecular diagnostics, and rapid antigen tests creates pricing pressures and market share challenges. Nevertheless, significant opportunities exist in expanding applications within emerging markets, where improving healthcare infrastructure and increasing disposable incomes are driving demand for diagnostic services. The growing focus on personalized medicine, companion diagnostics, and biomarker discovery presents new avenues for market growth, while the integration of artificial intelligence and digital health platforms offers potential for enhanced assay performance and data management capabilities.

Key Features of the Study

• This report provides in-depth analysis of the global enzyme immunoassay market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global enzyme immunoassay market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Abbott, Roche Diagnostics, Siemens Healthineers, bioMerieux, Beckman Coulter (Danaher), Thermo Fisher Scientific, Bio-Rad Laboratories, Revvity (PerkinElmer), DiaSorin, QuidelOrtho, EUROIMMUN (a Revvity company), Randox Laboratories, Bio-Techne (R&D Systems), Merck KGaA (MilliporeSigma), and Tecan
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global enzyme immunoassay market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global enzyme immunoassay market

Market Segmentation

• Product Type Insights (Revenue, USD Bn, 2020 - 2032)
  • Reagents and Kits
  • Analyzers/Instruments
  • Software and Automation Systems
  • Consumables and Accessories
• Technology Insights (Revenue, USD Bn, 2020 - 2032)
  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Enzyme-Linked Fluorescent Assay (ELFA)
  • Chemiluminescent Enzyme Immunoassay (CL-EIA)
  • Rapid Test Enzyme Immunoassay
  • Multiplex Enzyme Immunoassay
• Application Insights (Revenue, USD Bn, 2020 - 2032)
  • Infectious Disease Diagnostics
  • Oncology
  • Cardiology
  • Autoimmune Diseases
  • Endocrinology
  • Drug Monitoring and Toxicology
  • Allergy Testing
  • Others
• Specimen Type Insights (Revenue, USD Bn, 2020 - 2032)
  • Blood/Serum
  • Urine
  • Saliva
  • Tissue Samples
  • Others (CSF, Plasma)
• Automation Level Insights (Revenue, USD Bn, 2020 - 2032)
  • Manual
  • Semi-automated
  • Fully automated
• End User Insights (Revenue, USD Bn, 2020 - 2032)
  • Hospitals and Clinics
  • Diagnostic Laboratories
  • Research and Academic Institutes
  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organizations (CROs)
• Regional Insights (Revenue, USD Bn, 2020 - 2032)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • Abbott
  • Roche Diagnostics
  • Siemens Healthineers
  • bioMerieux
  • Beckman Coulter (Danaher)
  • Thermo Fisher Scientific
  • Bio-Rad Laboratories
  • Revvity (PerkinElmer)
  • DiaSorin
  • QuidelOrtho
  • EUROIMMUN (a Revvity company)
  • Randox Laboratories
  • Bio-Techne (R&D Systems)
  • Merck KGaA (MilliporeSigma)
  • Tecan

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Enzyme Immunoassay Market, By Product Type
  • Global Enzyme Immunoassay Market, By Technology
  • Global Enzyme Immunoassay Market, By Application
  • Global Enzyme Immunoassay Market, By Specimen Type
  • Global Enzyme Immunoassay Market, By Automation Level
  • Global Enzyme Immunoassay Market, By End User
  • Global Enzyme Immunoassay Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Driver
• Restraint
• Opportunity
• Impact Analysis
• Key Developments
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario
• Industry Trends

4. Global Enzyme Immunoassay Market, By Product Type, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Reagents and Kits
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Analyzers/Instruments
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Software and Automation Systems
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Consumables and Accessories
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Enzyme Immunoassay Market, By Technology, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Enzyme-Linked Immunosorbent Assay (ELISA)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Enzyme-Linked Fluorescent Assay (ELFA)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Chemiluminescent Enzyme Immunoassay (CL-EIA)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Rapid Test Enzyme Immunoassay
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Multiplex Enzyme Immunoassay
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Enzyme Immunoassay Market, By Application, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Infectious Disease Diagnostics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Oncology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Cardiology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Autoimmune Diseases
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Endocrinology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Drug Monitoring and Toxicology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Allergy Testing
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Enzyme Immunoassay Market, By Specimen Type, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Blood/Serum
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Urine
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Saliva
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Tissue Samples
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others (CSF, Plasma)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Enzyme Immunoassay Market, By Automation Level, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Manual
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Semi-automated
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Fully automated
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Enzyme Immunoassay Market, By End User, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Hospitals and Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Diagnostic Laboratories
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Research and Academic Institutes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Pharmaceutical and Biotechnology Companies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Contract Research Organizations (CROs)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

10. Global Enzyme Immunoassay Market, By Region, 2020 - 2032, Value (USD Bn)

• Introduction
  • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
  • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Specimen Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Automation Level, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Specimen Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Automation Level, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Specimen Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Automation Level, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Specimen Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Automation Level, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Specimen Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Automation Level, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Specimen Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Automation Level, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
    • South Africa
    • North Africa
    • Central Africa

11. Competitive Landscape

• Abbott
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Roche Diagnostics
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Siemens Healthineers
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• bioMerieux
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Beckman Coulter (Danaher)
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Thermo Fisher Scientific
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Bio-Rad Laboratories
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Revvity (PerkinElmer)
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• DiaSorin
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• QuidelOrtho
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• EUROIMMUN (a Revvity company)
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Randox Laboratories
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Bio-Techne (R&D Systems)
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Merck KGaA (MilliporeSigma)
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Tecan
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies

12. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

13. References and Research Methodology

• References
• Research Methodology
• About us